SBI Mutual Fund, under its various schemes, has disposed net sale of 7.54 million shares representing 9.53 per cent of the ...
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 ...
Four S&P/ASX 200 Index (ASX: XJO) stocks have done more than their share of the heavy lifting this week. Here’s what you need ...
Q4 2024 Management View CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ...
Good day, and welcome to the Designer Brands Inc. fourth-quarter 2024 earnings call. [Operator instructions] Please note, ...
Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweight Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results